Learning objectives and clinical implications
- Understand the mechanisms of action of biologic agents (e.g., TNF-α, IL-1, IL-6 inhibitors) and how they target specific inflammatory pathways in pediatric diseases.
- Identify approved indications for biologics in children, including juvenile idiopathic arthritis, inflammatory bowel disease, and pediatric psoriasis.
- Recognize the clinical criteria for initiating biologic therapy, particularly in cases of moderate-to-severe disease or inadequate response to conventional treatments.
- Evaluate the efficacy of biologics in achieving disease remission, improving quality of life, and preventing long-term complications such as organ damage or growth delay.
- Assess the safety profile and potential adverse effects, including infections, infusion reactions, and immunogenicity.
- Emphasize the importance of pre-treatment screening and ongoing monitoring (e.g., tuberculosis, hepatitis, vaccination status).
- Apply individualized treatment strategies based on disease severity, comorbidities, and patient-specific factors to optimize outcomes.
- Highlight the need for long-term follow-up and multidisciplinary care to ensure adherence, monitor response, and manage adverse events effectively.